To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage
To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage
Recruiting · NCT06376474 · Registry updated 2025-12-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder | Recruiting | Phase 1 | 2025-12-04 | NCT06376474 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ganzhou Hemay Pharmaceutical Co., Ltd | 8 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Union Hospital of Tongji Medical College; Huazhong University of Science and Technology | Wuhan | China | 1 |